{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for deucravacitinib in Related Substance Name (approximate match)
Showing 1 - 10 of 10 results
Status:
US Approved Rx
(2022)
Source:
NDA214958
(2022)
Source URL:
First approved in 2022
Source:
NDA214958
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Status:
US Approved Rx
(2013)
First approved in 1958
Class:
MIXTURE
Status:
Investigational
Source:
NCT00004070: Phase 1/Phase 2 Interventional Completed Head and Neck Cancer
(1999)
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
NCT00172809: Phase 4 Interventional Completed Chronic Hepatitis C
(2005)
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2022)
Source:
NDA214958
(2022)
Source URL:
First approved in 2022
Source:
NDA214958
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
